This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Newman Ferrara LLP has begun an investigation into potential claims against the board of directors of Cymer Inc. (“Cymer”) (Nasdaq: CYMI) concerning the proposed acquisition of Cymer by ASML Holding (“ASML”) (Nasdaq: ASML).
On October 17, 2012, Cymer announced that it had entered into an agreement and plan of merger to be acquired by ASML in a cash-and-stock transaction valued at approximately $1.5 billion. Under the agreement, Cymer shareholders will receive consideration in the form of $20.00 in cash and 1.15502 ASML ordinary shares of stock for each share of Cymer common stock owned. Cymer’s Board of Directors has unanimously approved the proposed acquisition which is expected to close during the first half of 2013.
Newman Ferrara LLP’s investigation concerns the potential unfairness and inadequacy of the offer price being provided to Cymer shareholders and the process by which Cymer’s Board of Directors approved the proposed transaction.
Concerned investors are encouraged to contact Newman Ferrara attorney Roy Shimon at (212) 619-5400 or
firstname.lastname@example.org to discuss this investigation, their rights, or potential remedies.
Newman Ferrara maintains a multifaceted practice based in New York City with attorneys specializing in complex commercial and multi-party litigation, securities fraud and shareholder litigation, consumer protection, civil rights, and real estate. For more information, please visit the firm website at